A Model to Evaluate the Impact of Hospital-Based Interventions Targeting False-Positive Blood Cultures on Economic and Clinical Outcomes

Blood culture contamination increases length of stay and leads to unnecessary antimicrobial therapy and hospital-acquired conditions. Our objective was to quantify the magnitude of additional length-of-stay costs to hospitals and society, and harm to patients, attributable to blood culture contamination.